Skip to main content
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
40.14
+1.74 (4.53%)
Nov 20, 2024, 4:00 PM EST - Market closed

Legend Biotech Revenue

Legend Biotech had revenue of $160.21M in the quarter ending September 30, 2024, with 66.86% growth. This brings the company's revenue in the last twelve months to $520.18M, up 122.96% year-over-year. In the year 2023, Legend Biotech had annual revenue of $285.14M with 143.70% growth.

Revenue (ttm)
$520.18M
Revenue Growth
+122.96%
P/S Ratio
14.08
Revenue / Employee
$284,876
Employees
1,826
Market Cap
7.36B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023285.14M168.14M143.70%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M13.20M21.36%
Jan 1, 202061.80M12.31M24.86%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.81B
Bausch + Lomb 4.68B
Elanco Animal Health 4.45B
Jazz Pharmaceuticals 3.99B
Merit Medical Systems 1.33B
Repligen 639.92M
Ascendis Pharma 365.19M
Cytokinetics 3.22M
Revenue Rankings

LEGN News

More News